Oxcarbazepine/topiramateMultiple fetal anomalies following in utero exposure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1407卷 / 1期

关键词：

Lower Extremity; Urinary Bladder; Topiramate; Fluid Collection; Left Kidney;

D O I：

10.2165/00128415-201214070-00115

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：32 / 32

相关论文

共 50 条

[1] Clonazepam/lamotrigineMultiple fetal anomalies leading to fetal death following in utero exposure: case report
Reactions Weekly, 2010, 1316 (1) : 15 - 16
[2] MethotrexateFetal anomalies following in utero exposure: case report
Reactions Weekly, 2009, 1281 (1) : 22 - 22
[3] ThiamazoleCongenital anomalies following in utero exposure: case report
Reactions Weekly, 2012, 1389 (1) : 40 - 40
[4] MethotrexateFetal anomalies following in utero exposure: case report
Reactions Weekly, 2011, 1374 (1) : 25 - 25
[5] Oxcarbazepine withdrawalNeonatal abstinence syndrome following an in utero exposure: case report
Reactions Weekly, 2017, 1665 (1) : 220 - 220
[6] ImatinibMultiple congenital anomalies following in utero exposure: case report
Reactions Weekly, 2015, 1557 (1) : 121 - 121
[7] CarbimazoleMultiple congenital anomalies following in utero exposure: case report
Reactions Weekly, 2012, 1395 (1) : 13 - 13
[8] BupropionCongenital cardiac anomalies following in utero exposure: case report
Reactions Weekly, 2015, 1569 (1) : 50 - 50
[9] MethotrexateMultiple congenital anomalies following in utero exposure: case report
Reactions Weekly, 2010, 1315 (1) : 33 - 34
[10] IsotretinoinCongenital anomalies following in-utero exposure: case report
Reactions Weekly, 2017, 1661 (1) : 186 - 186

← 1 2 3 4 5 →